CARAWAY THERAPEUTICS
Rheostat’s mission is to invent novel treatments for neurodegenerative disease through modulation of mitophagy and autophagy. They believe that the degradation of toxic cellular components, whether they are damaged organelles or aggregated proteins, is a fundamental node of biology. Mutations that impair these clearance pathways cause multiple neurodegenerative diseases, many of which are associated with cognitive impairment. They aim to leverage our understanding of these critical pathways to discover and develop novel small molecules that will restore cellular balance and treat neurodegenerative and rare diseases.
CARAWAY THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2018-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.carawaytx.com
Total Employee:
11+
Status:
Active
Total Funding:
23 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail GoDaddy DNS AWS Global Accelerator
Similar Organizations
Emendo Biotherapeutics
Emendo Biotherapeutics is a biotechnology company
Current Advisors List
Current Employees Featured
Founder
Investors List
Michael J. Fox Foundation
Michael J. Fox Foundation investment in Grant - Caraway Therapeutics
MRL Ventures Fund
MRL Ventures Fund investment in Venture Round - Caraway Therapeutics
Dementia Discovery Fund
Dementia Discovery Fund investment in Series A - Caraway Therapeutics
AbbVie Biotech Ventures
AbbVie Biotech Ventures investment in Series A - Caraway Therapeutics
Mayo Clinic
Mayo Clinic investment in Series A - Caraway Therapeutics
SV Health Investors
SV Health Investors investment in Series A - Caraway Therapeutics
MRL Ventures Fund
MRL Ventures Fund investment in Series A - Caraway Therapeutics
Amgen Ventures
Amgen Ventures investment in Series A - Caraway Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Caraway Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2019-12-03 | Caraway Therapeutics Names Martin Williams as CEO |
Official Site Inspections
http://www.carawaytx.com Semrush global rank: 4.9 M Semrush visits lastest month: 1.78 K
- Host name: af6f849e18e4a0c33.awsglobalaccelerator.com
- IP address: 3.33.166.197
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Caraway Therapeutics"
MSD to Acquire Caraway Therapeutics, Inc. - MSD
Nov 21, 2023 For more information, please visit www.carawaytx.com. About MSD. At MSD, known as Merck & Co., Inc., Rahway, N.J., USA in the United States and Canada, we are …See details»
Caraway Therapeutics, Inc. | LinkedIn
Caraway Therapeutics, Inc. Biotechnology Research Cambridge, MA 2,095 followers a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Precision Medicines for CNS and Rare …See details»
Merck to Acquire Caraway Therapeutics, Inc. - Merck.com
Nov 21, 2023 Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases Merck (NYSE: MRK), known as MSD outside of the United …See details»
Merck to Acquire Caraway Therapeutics, Inc. | Business Wire
Nov 21, 2023 RAHWAY, N.J., & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Caraway Therapeutics, …See details»
Caraway Therapeutics Company Profile | Management and
[email protected]: Caraway Therapeutics Top Competitors. Company Employees Revenue Top technologies; Collaborative Medicinal Development LLC. 22: $4.4 M: The Column Group …See details»
Caraway Therapeutics - Overview, News & Similar companies
Apr 11, 2023 Who is Caraway Therapeutics. Caraway Therapeutics is a biopharmaceutical company pursuing novel approaches for the treatment of genetically defined …See details»
Caraway Therapeutics, Inc. Company Profile | Cambridge, MA ...
Find company research, competitor information, contact details & financial data for Caraway Therapeutics, Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Caraway Therapeutics, Inc. Overview | SignalHire Company Profile
Organization Website: carawaytx.com : Social Links: Phone Number (617) 245-8188: Caraway Therapeutics... industries Biotech: Headquarters Location: 300 Technology Square, …See details»
Caraway Therapeutics - Ownership and Business Overview - Mergr
Nov 21, 2023 www.carawaytx.com. Profile Investors (1) Analytics Caraway Therapeutics is specialized in treatment of neurodegenerative and rare diseases by targeting pathways …See details»
Caraway Therapeutics - PitchBook
Caraway Therapeutics General Information Description. Developer of novel drug designed for doctors to treat neurodegenerative diseases. The company develops treatments that modulate …See details»
Caraway Therapeutics, Inc. - Company Profile & Staff Directory
Caraway Therapeutics, Inc. is a Biotechnology company located in 300 Technology Square, Suite 201, Cambridge, MA 02139, US with 22 employees. Access Caraway Therapeutics, Inc.'s …See details»
Caraway Therapeutics Company Profile -Sales, Contacts, …
Www.carawaytx.com: There are 17 Companies located at 300 TECHNOLOGY SQ, Cambridge, MA 02139 Map View larger ... This organization primarily operates in the Rheostats business / …See details»
Caraway Therapeutics - Craft
Caraway Therapeutics is a company that discovers drugs for neurodegenerative diseases. It uses genetic data and biology to develop small molecules that activate neurons’ clearance and …See details»
Caraway Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Www.carawaytx.com. Startups | Subsidiary Company | 2018 | Massachusetts, United States | 10-50 | www.carawaytx.com. Last update 07 Mar 2025 ... The statistics for drugs in the Pipeline is …See details»
Caraway Therapeutics, Inc. Information - RocketReach
What is the annual revenue of Caraway Therapeutics, Inc.? The Caraway Therapeutics, Inc. annual revenue was $4 million in 2024.See details»
Merck to Acquire Caraway Therapeutics, Inc. - BioSpace
Nov 21, 2023 Merck and Caraway Therapeutics, Inc. announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire …See details»
Caraway Therapeutics - Work in biotech
Caraway Therapeutics is inventing novel treatments for neurodegenerative diseases by modulating the lysosome. The lysosome is the cell’s recycling center that clears toxic materials …See details»
Nextsource | Company Profile | Caraway Therapeutics
Explore the company profile of Caraway Therapeutics (carawaytx.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Caraway Therapeutics to Present at Two Upcoming Investor …
Oct 7, 2022 For more information, please visit www.carawaytx.com. Contacts. Media: MacDougall Kari Watson or Carolyn Noyes (781) 235-3060 [email protected] or …See details»
Caraway Therapeutics Establishes Collaboration with AbbVie
Jun 9, 2021 Caraway Therapeutics announced an exclusive, collaboration and option agreement with AbbVie to develop and commercialize Caraway’s small molecule therapeutics targeting …See details»